Skip to main content
OpenTrials
Completed

NCT Number: NCT06905158

Evaluation of a Non-invasive Tinnitus Device for the Management of Tinnitus Symptoms in Military Veterans

The prevalence of tinnitus in military veterans is notably higher than the non-veteran population and can significantly disrupt the lives of veterans. Given the profound impact of tinnitus on the lives of veterans, along with the considerable economic burden and barriers to treatment, it is crucial to explore the feasibility of new approaches. Wearable sound technologies offer a non-invasive and easily accessible approach. As such, this waitlist-controlled trial aims to assess the efficacy of this new non-invasive white noise wearable device in reducing tinnitus symptoms between baseline and the one-month post-randomisation among veterans who have experienced tinnitus for at least three months.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Combat Stress

Leatherhead, KT22 0BX, United Kingdom

About this study

The presence of tinnitus has been significantly associated with depression, anxiety, sleep difficulties and job performance in addition to poorer general physical health.. However, to our knowledge, there is currently no intervention for tinnitus that is supported as effective for most people. As such, there is a need to explore alternative approaches. Sound therapy offers an easily accessible, non-invasive, low-cost option. As such, this study aims to explore the effectiveness of a non-invasive white noise device in reducing symptoms of tinnitus and mental health difficulties in military veterans. A total of 20 military veterans who have self-reported experiencing tinnitus for at least three months will be recruited. : In this waitlist-controlled trial, the tinnitus device will be compared to the waitlist-controlled group who will receive the device one-month post-randomisation. The trial will be conducted in a veteran population (n = 20) that was recruited from a prior study that had aimed to explore the impact of tinnitus on wellbeing within a veteran population. Once the participants receive the tinnitus device, they will be asked to use the device for a period of one month. The primary outcome is the change in self-reported tinnitus symptoms and mental health difficulties between baseline (day 0) and the one-month post-randomisation (day 28). The outcome variables of interest will be assessed at all timepoints (baseline, one-month post-randomisation, and two-months post-randomisation) and the predictor variables will only be assessed at baseline to reduce participant burden. It is hypothesised that the non-invasive device will result in significant reductions in symptoms of tinnitus (as indicated using the TFI) and mental health difficulties (as measured using the gHQ-12) from baseline to one-month post-intervention in comparison to a waitlist control.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Fluent in speaking and reading English.
  • United Kingdom Armed Forces veteran
  • Persistent tinnitus for at least three months (participants with tinnitus had to confirm experience of constant ringing or buzzing [bilateral or unilateral] lasting longer than three months).
  • Able to receive the TinniSoothe device to their registered address
  • Able to follow study instructions
  • Sign the written consent form prior to any study-related procedures being performed

Exclusion criteria

  • Below 18 years of age
  • Significant severe hearing loss without hearing aids
  • Individuals who have already habituated to tinnitus
  • Veterans receiving concurrent treatment for tinnitus (e.g., other wearable devices or ongoing audiological therapies)
  • Active self-harm or suicidal ideation
  • Severe psychotic disorder, dissociative identity disorder or other severe mental health difficulty
  • Current alcohol or drug-use disorder or dependency requiring further support or treatment that would significantly impact treatment engagement, as assessed clinician
  • Unwilling and/or unable to provide informed consent

Treatment and study plan

White noise device

Device
  • Product name: TinniSoothe white noise-non-invasive tinnitus device
  • Usage: Worn around the neck during the daytime and docked to a stand at night
  • Duration: At least one-month of use

Other names: TinniSoothe, Non-invasive white noise device, Tinnitus sound device

Primary outcomes

  1. Symptoms of tinnitus measured using the Tinnitus Functional Index (TF)

    Time frame: [Time Frame: Change from baseline TFI score at one-month post-randomisation and two-months post-randomisation]

    Scores range from 0-250, with higher scores indicating greater tinnitus symptoms

  2. Symptoms of mental health difficulties measured using the General Health Questionnaire-12

    Time frame: [Time Frame: Change from baseline General Health Questionnaire-12 score at one-month post-randomisation and two-months post-randomisation]

    Scores range from 0-36, with higher scores indicating greater psychological distress

Secondary outcomes

  1. Satisfaction of life as measured using the Satisfaction with life Scale (SWLS)

    Time frame: [Time Frame: Change from baseline SWLS score at one-month post-randomisation and two-months post-randomisation]

    Scores range from 5-35, with a higher score indicating greater life satisfaction.

  2. Sleep as measured using the Insomnia Severity Index (ISI)

    Time frame: [Time Frame: Change from baseline ISI score at one-month post-randomisation and two-months post-randomisation]

    Scores range from 0-28, with a higher score indicating greater insomnia severity.

Other outcomes

  1. Symptoms of PTSD as measured using the Posttraumatic Stress Disorder Checklist For Diagnostic and Statistical Manual of Mental Disorders-5- Short Version (PCL- 5-4)

    Time frame: [Time Frame: Predictor variable]

    A 4-item measure of the presence of PTSD symptoms according to the Diagnostic and Statistical Manual of Mental Disorders-IV. Scores range from 0-16, with a higher score indicating more severe PTSD

  2. Physical health and somatic symptoms as measured using the Patient Health Questionnaire-15

    Time frame: [Time Frame: Predictor variable]

    Scores range from 0-30, with higher scores indicating greater severity of physical health and somatic symptoms

  3. Qualitative questionnaire

    Time frame: [Time Frame: Consenting participants will be contacted at one-month post-randomisation for the immediate intervention group and two-months post-randomisation for the waitlist control group]

    Consenting participants will be contacted at one-month post-randomisation for the immediate intervention group and two-months post-randomisation for the waitlist control group

  4. Retention rate

    Time frame: [Time Frame: Intervention end (approximately 1 year)]

    Feasibility endpoint

  5. • Recruitment of target sample size (n = 20)

    Time frame: [Time Frame: Study end (approximately 1 year)]

    Feasibility endpoint

  6. Incidence of adverse events across the duration of the study

    Time frame: [Time Frame: Study end (approximately 1 year)]

    Safety endpoint, calculated as total number of adverse events reported across the study. Adverse events as defined in the study protocol. Adverse events will be reported in the qualitative questionnaire post-intervention.

Sponsors and collaborators

Lead sponsor

Combat Stress

Other

Registry information

Official study title

Evaluating the Effectiveness of a Non-invasive Tinnitus Device in Reducing Symptoms of Tinnitus and Mental Health Difficulties in Military Veterans: A Pilot Randomised Controlled Trial

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Apr 1, 2025
Registry last updated
Mar 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.